AC Immune SA
ACIU
Get informed when a big investor buys or sells
+ FollowMarket Cap$240.19M
Close$
$-0.09
103.5% downside
Current Fair Value
103.5% downsideOvervalued by 103.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $240.19 Million |
|---|---|
| Enterprise Value | $307.30 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.7 |
| Beta | 1.57 |
| Outstanding Shares | 98,673,333 |
Return
| Return on Equity | -122.41% |
|---|---|
| Return on Assets | -28.62% |
| Return on Invested Capital | -85.46% |
Valuation & Multiples
| P/E Ratio | -2.89 |
|---|---|
| PEG | 2.65 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 17.71 |
| Enterprise Value to EBIT | -7.17 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 2.7 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
$9.59 M
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$-0.22
Average shareholder expectationRevenue Estimate
$248,685
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 10.00% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.61%▼ 24.81% |
|---|---|
| Total Invested | $1.43M▼ 97.93% |
| Investors Holding | 15▼ 36.00% |
ESG Score
No data
About AC Immune SA
CEO: Andrea Pfeifer